Medications for Granulomatosis With Polyangiitis

3 results

  • rituxan

    (rituximab)
    Genentech, Inc.
    RITUXAN is indicated for the treatment of various conditions including Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA), and Pemphigus Vulgaris (PV) in adults and pediatric patients, as specified.

  • ruxience

    (rituximab-pvvr)
    Pfizer Laboratories Div Pfizer Inc
    RUXIENCE is indicated for adult patients with relapsed or refractory non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and granulomatosis with polyangiitis and microscopic polyangiitis, often in combination with other therapies, depending on the specific condition and patient response.

  • tavneos

    (avacopan)
    ChemoCentryx, Inc.
    TAVNEOS is indicated as an adjunctive treatment for adults with severe active ANCA-associated vasculitis (granulomatosis with polyangiitis or microscopic polyangiitis) in conjunction with standard therapy, including glucocorticoids, which it does not replace.